BMI as a predictor of progression from TB infection to active TB in PLHIV
The International Journal of Tuberculosis and Lung Disease · 2025
DOI: 10.5588/ijtld.24.0287 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The International Journal of Tuberculosis and Lung Disease, 2025. Verfasst von D Nguenha und 12 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique;, Department of Global Health and Amsterdam Institute for Global Health and Dev…. Hauptthemen laut MEDLINE: Body Mass Index, HIV Infections, Tuberculosis, Antitubercular Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
BACKGROUND
Low body mass index (BMI) is a globally important risk factor for TB progression. Little is known about this association in people living with HIV (PLHIV) and the functional form of the BMI-TB incidence curve.
METHODS
Secondary analysis of a randomised controlled trial of TB preventive therapy among PLHIV in South Africa, Mozambique, and Ethiopia. Participants received 3 months of weekly high-dose rifapentine-isoniazid given once or twice over a period of 2 years. Multivariable fractional polynomials (MFPs) were used to investigate functional forms of BMI. Time to incident TB was modelled using Cox’s proportional hazard regression.
RESULTS
A total of 76 TB events were documented, giving an overall TB incidence rate of 1.2 per 100 person-years (95%CI 1.0–1.6). Baseline BMI 25 kg/m 2 .
CONCLUSIONS
In PLHIV, BMI showed an inverse log-linear association with TB incidence. The MFP approach showed that the relationship is more complex than a simple log-linear association.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique;, Department of Global Health and Amsterdam Institute for Global Health and Development, Amsterdam University Medical Centers, Location University of…
- The Aurum Institute, Johannesburg, South Africa.
- Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique;, ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
- Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
- The Aurum Institute, Johannesburg, South Africa;, School of Public Health, University of Witwatersrand, Johannesburg, South Africa;, Department of Medicine, Vanderbilt University, Nashville, TN, USA.
- London School of Hygiene & Tropical Medicine (LSHTM), London, UK.
Zitieren
APA
Nguenha, D., Ndebele, F., Saavedra, B., Mambuque, E., Acácio, S., Cárdenas, V., Chihota, V., Grant, A., Yimer, G., Fielding, K., Cobelens, F., Churchyard, G., & Garcia-Basteiro, A. L. (2025). BMI as a predictor of progression from TB infection to active TB in PLHIV. The International Journal of Tuberculosis and Lung Disease. https://doi.org/10.5588/ijtld.24.0287
Vancouver
Nguenha D, Ndebele F, Saavedra B, Mambuque E, Acácio S, Cárdenas V, et al. BMI as a predictor of progression from TB infection to active TB in PLHIV. The International Journal of Tuberculosis and Lung Disease. 2025. doi:10.5588/ijtld.24.0287
BibTeX
@article{Nguenha2025,
author = {Nguenha, D and Ndebele, F and Saavedra, B and Mambuque, E and Acácio, S and Cárdenas, V and Chihota, V and Grant, A and Yimer, G and Fielding, K and Cobelens, F and Churchyard, G and Garcia-Basteiro, A L},
title = {BMI as a predictor of progression from TB infection to active TB in PLHIV},
journal = {The International Journal of Tuberculosis and Lung Disease},
year = {2025},
doi = {10.5588/ijtld.24.0287}
}
EUVIMED